Last Updated: June 17, 2026

Annora Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ANNORA

ANNORA has sixty-one approved drugs.

There are eight tentative approvals on ANNORA drugs.

Summary for Annora

US Patents:	0
Tradenames:	52
Ingredients:	52
NDAs:	61
Patent Litigation for Annora:	See patent lawsuits for Annora

Drugs and US Patents for Annora

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Annora Pharma	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	217898-002	Oct 1, 2025	AB3	RX	No	No		⤷ Start Trial				⤷ Start Trial
Annora	APREMILAST	apremilast	TABLET;ORAL	211878-003	Jul 26, 2023	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Annora Pharma	PAROXETINE HYDROCHLORIDE	paroxetine hydrochloride	SUSPENSION;ORAL	219954-001	Mar 5, 2026	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Annora Pharma	DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM	diatrizoate meglumine; diatrizoate sodium	SOLUTION;ORAL, RECTAL	215049-001	Nov 17, 2023	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.